Results from two Phase III studies of Firazyr published recently in the New England Journal of Medicine demonstrate the efficacy and favourable safety profile of icatibant for the treatment of Hereditary Angioedema (HAE) attacks. The FAST-1 and FAST-2 studies The FAST-1 and FAST-2 studies were double-blind randomised multicenter trials designed to evaluate the effect of [...]
Efficacy and Favourable Safety Profile of Firazyr (icatibant) for the Treatment of Hereditary Angioedema attacks
September 2, 2010 By
Actavis Piperacillin/Tazobactum
September 1, 2010 By
Company: Actavis Ireland Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredients: Piperacillin Na+/tazobactam Na+ 2.25g (2g/0.25g), 4.5g (4g/0.5g). Description: Powder for solution for injection or infusion. Presentation: Prices on request. Indications: Treatment of moderate to severe systemic and/or local bacterial infections in which β-lactamase producing bacteria are suspected or have been detected. Adults/adolescents/elderly: Nosocomial [...]
Cefuroxime Teva
September 1, 2010 By
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Cefuroxime 250mg, 500mg. Description: Light blue film-coated tablets marked either 250 or 500 on one side and P125 or P126 on reverse, resp. Presentation: 250mg-14, €5.34: 500mg-14, €10.16. Indications: Mild to moderately severe infections such as upper respiratory tract infections (acute otitis media, [...]
Omeprazole Actavis
September 1, 2010 By
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Omeprazole 10mg, 20mg, 40mg. Description: Gastro-resistant, hard capsules. 10mg, 20mg: Opaque yellow. 40mg: Opaque blue and white. Presentation: 10mg-28; 20mg-28; 40mg-14. Prices available on request. Indications: Treatment of duodenal ulcers; benign gastric ulcers; reflux oesophagitis (RO); Zollinger-Ellison syndrome (ZES); NSAID related gastric and [...]
Simponi
September 1, 2010 By
Company: MSD. Legal category: Prescription. High Tech. Sports permitted. Active ingredient: Golimumab 50mg/0.5ml. Description: Solution for injection in pre-filled pen. Presentation: Price available on request. Indications: Treatment of moderate to severe, active rheumatoid arthritis in combination with methotrexate (MTX) when the response to disease-modifying anti-rheumatic drug (DMARD) therapy [...]
Urorec
September 1, 2010 By
Company: Recordati Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Silodosin 4mg, 8mg. Description: Resp. yellow or white, opaque, hard gelatin capsules. Presentation: 4mg-30, €19.80; 8mg-30, €19.80. Indication: Treatment of the symptoms of benign prostatic hyperplasia (BPH). Pharmacology: Silodosin is highly selective for α1A‑adrenoreceptors that are primarily located in the human prostate, bladder [...]
Zolpidem Tartrate Teva
September 1, 2010 By
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Zolpidem (tartrate) 5mg, 10mg. Description: White, oval, biconvex, film-coated tablets marked ZIM on one side and 5 on reverse or ZIM10 on one side, resp. Presentation: 5mg-28, €1.32; 10mg-28, €2.64. Indication: Short term treatment of insomnia. Pharmacology: Zolpidem is a non-benzodiazepine hypnotic agent [...]
Actavis Gemcitabine 2g
September 1, 2010 By
Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Gemcitabine (as HCl) 2g. Description: Powder for solution for infusion. Presentation: Vial. Price available on request. Indications: Locally advanced or metastatic bladder cancer in combination with cisplatin. Locally advanced or metastatic adenocarcinoma of the pancreas. In combination with cisplatin, first line treatment of patients [...]
Desmotabs Melt
September 1, 2010 By
Company: Ferring Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Desmopressin (free base) 240mcg (as desmopressin acetate). Description: White, round, oral lyophilisate marked with three drop shaped figures on one side. Presentation: 30, €78.24. Indications: Diagnosis and treatment of cranial diabetes insipidus including post-hypophysectomy polyuria/polydipsia and treatment of primary nocturnal enuresis in patients [...]
Glucophage Powder
September 1, 2010 By
Company: Merck Serono. Legal Category: Prescription. GMS. Sport permitted. Active ingredient: Metformin (HCl) 500mg. Description: White, odourless powder for oral solution. Presentation: 500mg-30 sachets, €2.23. Indications: Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control (alone or with other oral antidiabetic [...]